Basic information Safety Supplier Related

HVRLZEKDTUEKQH-NEGCSKJWSA-N

Basic information Safety Supplier Related

HVRLZEKDTUEKQH-NEGCSKJWSA-N Basic information

Product Name:
HVRLZEKDTUEKQH-NEGCSKJWSA-N
Synonyms:
  • HVRLZEKDTUEKQH-NEGCSKJWSA-N
  • [2H3]- Olopatadine Hydrochloride
  • 2-[(11Z)-11-[3-[methyl(trideuteriomethyl)amino]propylidene]-6H-benzo[c][1]benzoxepin-2-yl]acetic acid
CAS:
1331635-21-2
MF:
C21H21ClD3NO3
MW:
376.891645334
Mol File:
1331635-21-2.mol
More
Less

HVRLZEKDTUEKQH-NEGCSKJWSA-N Chemical Properties

storage temp. 
Store at -20°C
solubility 
Methanol: Slightly soluble,
form 
A solid
Water Solubility 
Water: Slightly soluble
More
Less

HVRLZEKDTUEKQH-NEGCSKJWSA-N Usage And Synthesis

Uses

Labelled Olopatadine. Dual acting histamine H1-receptor antagonist and mast cell stabilizer. Antiallergic; antihistaminic.

Biological Activity

Olopatadine-d3 is intended for use as an internal standard for the quantification of olopatadine by GC- or LC-MS. Olopatadine is a histamine H1 receptor antagonist (Ki =41 nM).1 It is 1,059- and 4,177-fold selective for histamine H1 over H2 and H3 receptors, respectively. Olopatadine inhibits histamine-induced phosphoinositide turnover in isolated human conjunctival epithelial cells, isolated human corneal fibroblasts, and human trabecular meshwork (TM3) cells (IC50s = 9.5, 19, and 39.9 nM, respectively). In vivo, olopatadine inhibits passive cutaneous anaphylaxis in rats (ED50 = 49 μg/kg) and IgG1-mediated bronchoconstriction in ovalbumin-sensitized guinea pigs (ED50 = 30 μg/kg).2 Formulations containing olopatadine have been used in the treatment of allergic rhinitis and conjunctivitis, as well as in the treatment of itch in patients with well-controlled urticaria.

References

1.Sharif, N.A., Xu, S.X., and Yanni, J.M.Olopatadine (AL-4943A): Ligand binding and functional studies on a novel, long acting H1-selective histamine antagonist and anti-allergic agent for use in allergic conjunctivitisJ. Ocul. Pharmacol. Ther.12(4)401-407(1996) 2.Ohshima, E., Otaki, S., Sato, H., et al.Synthesis and antiallergic activity of 11-(aminoalkylidene)-6,11-dihydrodibenz[b,e]oxepin derivativesJ. Med. Chem.35(11)2074-2084(1992)

HVRLZEKDTUEKQH-NEGCSKJWSA-NSupplier

Energy Chemical
Tel
021-58432009 400-005-6266
Email
marketing1@energy-chemical.com
Changzhou Xianglong Pharmaceutical Technology Co., LTD
Tel
0519-88910898 18661161657
Email
yaoxiangqiu2021@163.com
ChemeGen 中国
Tel
18818260767
Email
sales@chemegen.com
Shanghai Yifei Biotechnology Co. , Ltd.
Tel
021-65675885 18964387627
Email
customer_service@efebio.com
Nanjing Shizhou Biology Technology Co.,Ltd
Tel
17301488900
Email
judy.xia@synzest.com